Search

everythinglearnresearchcommunity

for

Search:↓

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

New medications could improve treatment for severe alopecia areata in Australia.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Various treatments can help manage hidradenitis suppurativa based on its severity.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.